Literature DB >> 2146239

Kinetic analysis of 5-fluorouracil action against various cancer cells.

M Inaba1, J Mitsuhashi, S Ozawa.   

Abstract

Based on our recent kinetic analysis, which made it possible to distinguish between the cell-killing actions of cell cycle phase-specific and non-specific agents, we attempted to elucidate the actions of 5-fluorouracil (FUra) on three different cancer cell lines. By colony-forming assay, the concentrations of fluorouridine (FUrd), fluorodeoxyuridine (FdUrd) or FUra giving 90% cell kill (IC90) at various exposure times (texps) were obtained. With P388 cells, the curve of texps-IC90 for FUrd on a log-log scale was linear with a slope of -1, which is typical for cell cycle phase-nonspecific agents. In contrast, the curve for FdUrd showed a much steeper slope than -1, which is characteristic for cell cycle phase-specific agents. We found that the curve for FUra was exactly the same as that for FUrd, indicating that the mode of FUra action on P388 leukemia is analogous to that of FUrd. Similar results were observed with human colon and renal cancer cell lines, HT-29 and KU-2, although when the cells were exposed to relatively low concentrations of FUra for a long time, a cell cycle phase-specific action became evident.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2146239      PMCID: PMC5917971          DOI: 10.1111/j.1349-7006.1990.tb03343.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  28 in total

1.  Cytotoxicity and the inhibition of ribosomal RNA processing in human colon carcinoma cells.

Authors:  M B Cohen; R I Glazer
Journal:  Mol Pharmacol       Date:  1985-02       Impact factor: 4.436

2.  Kinetic analysis of cell killing effect induced by cytosine arabinoside and cisplatin in relation to cell cycle phase specificity in human colon cancer and Chinese hamster cells.

Authors:  S Ozawa; Y Sugiyama; J Mitsuhashi; M Inaba
Journal:  Cancer Res       Date:  1989-07-15       Impact factor: 12.701

3.  The inhibitory effects of 5-fluorouracil on the metabolism of preribosomal and ribosomal RNA in L-1210 cells in vitro.

Authors:  R Kanamaru; H Kakuta; T Sato; C Ishioka; A Wakui
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Cell cycle phase specificity of antitumor agents.

Authors:  B K Bhuyan; L G Scheidt; T J Fraser
Journal:  Cancer Res       Date:  1972-02       Impact factor: 12.701

5.  Relationship of cellular folate cofactor pools to the activity of 5-fluorouracil.

Authors:  M B Yin; S F Zakrzewski; M T Hakala
Journal:  Mol Pharmacol       Date:  1983-01       Impact factor: 4.436

6.  Relationship between 5-fluoro-2'-deoxyuridylate, 2'-deoxyuridylate, and thymidylate synthase activity subsequent to 5-fluorouracil administration, in xenografts of human colon adenocarcinomas.

Authors:  J A Houghton; K D Weiss; L G Williams; P M Torrance; P J Houghton
Journal:  Biochem Pharmacol       Date:  1986-04-15       Impact factor: 5.858

7.  Binding of 5-fluorodeoxyuridylate to thymidylate synthase in human colon adenocarcinoma xenografts.

Authors:  J A Houghton; P M Torrance; S Radparvar; L G Williams; P J Houghton
Journal:  Eur J Cancer Clin Oncol       Date:  1986-04

Review 8.  Treatment of cultured human colon carcinoma cells with fluorinated pyrimidines.

Authors:  B Drewinko; L Y Yang; D H Ho; J Benvenuto; T L Loo; E J Freireich
Journal:  Cancer       Date:  1980-03-15       Impact factor: 6.860

9.  On the mechanism of cytotoxicity of fluorinated pyrimidines in four human colon adenocarcinoma xenografts maintained in immune-deprived mice.

Authors:  J A Houghton; P J Houghton
Journal:  Cancer       Date:  1980-03-15       Impact factor: 6.860

10.  Cell killing action of cell cycle phase-non-specific antitumor agents is dependent on concentration--time product.

Authors:  S Ozawa; Y Sugiyama; Y Mitsuhashi; T Kobayashi; M Inaba
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

View more
  14 in total

1.  Population pharmacokinetics and concentration-effect relationships of capecitabine metabolites in colorectal cancer patients.

Authors:  Ronald Gieschke; Hans-Ulrich Burger; Bruno Reigner; Karen S Blesch; Jean-Louis Steimer
Journal:  Br J Clin Pharmacol       Date:  2003-03       Impact factor: 4.335

2.  A pharmacodynamic and pharmacokinetic study of fluoropyrimidines in a nude mouse system and in postoperative patients with gastric cancer.

Authors:  T Inada; Y Ogata; T Kubota; I Ozawa; S Hishinuma; H Shimizu; K Kotake; T Ikeda; Y Koyama
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

3.  Thymidine phosphorylase activity and prodrug effects in a three-dimensional model of angiogenesis: implications for the treatment of ovarian cancer.

Authors:  D P Stevenson; W P Collins; F Farzaneh; K Hata; K Miyazaki
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

4.  In vivo antitumor activity of a novel sulfonamide, HMN-214, against human tumor xenografts in mice and the spectrum of cytotoxicity of its active metabolite, HMN-176.

Authors:  Manabu Takagi; Takuya Honmura; Shuuji Watanabe; Reiko Yamaguchi; Masaki Nogawa; Ikumi Nishimura; Fumitaka Katoh; Masato Matsuda; Hiroyoshi Hidaka
Journal:  Invest New Drugs       Date:  2003-11       Impact factor: 3.850

5.  Pharmacological effects of 5-fluorouracil microspheres on peritoneal carcinomatosis in animals.

Authors:  A Hagiwara; T Takahashi; K Sawai; C Sakakura; H Tsujimoto; T Imanishi; M Ohgaki; J Yamazaki; S Muranishi; A Yamamoto; T Fujita
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

6.  Carcinoembryonic Antigen Expression and Resistance to Radiation and 5-Fluorouracil-Induced Apoptosis and Autophagy.

Authors:  Ebrahim Eftekhar; Hajar Jaberie; Fakhraddin Naghibalhossaini
Journal:  Int J Mol Cell Med       Date:  2016-05-17

7.  Schedule-dependent interactions between raltitrexed and cisplatin in human carcinoma cell lines in vitro.

Authors:  Y Kano; M Akutsu; K Suzuki; Y Yazawa; S Tsunoda
Journal:  Jpn J Cancer Res       Date:  2000-04

8.  Circumvention of 5-fluorouracil resistance in human stomach cancer cells by uracil phosphoribosyltransferase gene transduction.

Authors:  M Inaba; H Sawada; A Sadata; H Hamada
Journal:  Jpn J Cancer Res       Date:  1999-03

9.  5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins.

Authors:  M E Nita; H Nagawa; O Tominaga; N Tsuno; S Fujii; S Sasaki; C G Fu; T Takenoue; T Tsuruo; T Muto
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

10.  Different modes of cell-killing action between DNA topoisomerase I and II inhibitors revealed by kinetic analysis.

Authors:  M Inaba; J Mitsuhashi; S Kawada; H Nakano
Journal:  Jpn J Cancer Res       Date:  1994-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.